[HTML][HTML] Long-term results for children with high-risk neuroblastoma treated on a randomized trial of myeloablative therapy followed by 13-cis-retinoic acid: a children's …
KK Matthay, CP Reynolds, RC Seeger… - Journal of clinical …, 2009 - ncbi.nlm.nih.gov
KK Matthay, CP Reynolds, RC Seeger, H Shimada, ES Adkins, D Haas-Kogan, RB Gerbing…
Journal of clinical oncology, 2009•ncbi.nlm.nih.govPurpose We assessed the long-term outcome of patients enrolled on CCG-3891, a high-risk
neuroblastoma study in which patients were randomly assigned to undergo autologous
purged bone marrow transplantation (ABMT) or to receive chemotherapy, and subsequent
treatment with 13-cis-retinoic acid (cis-RA).
neuroblastoma study in which patients were randomly assigned to undergo autologous
purged bone marrow transplantation (ABMT) or to receive chemotherapy, and subsequent
treatment with 13-cis-retinoic acid (cis-RA).
Abstract
Purpose
We assessed the long-term outcome of patients enrolled on CCG-3891, a high-risk neuroblastoma study in which patients were randomly assigned to undergo autologous purged bone marrow transplantation (ABMT) or to receive chemotherapy, and subsequent treatment with 13-cis-retinoic acid (cis-RA).
ncbi.nlm.nih.gov